APR Co., Ltd. (KRX:278470)
South Korea · Delayed Price · Currency is KRW | Market Cap | 13.70T +63.8% |
| Revenue (ttm) | 2.29T +126.7% |
| Net Income | 432.20B +146.1% |
| EPS | 11,509.33 +149.7% |
| Shares Out | 37.44M |
| PE Ratio | 31.80 |
| Forward PE | 19.61 |
| Dividend | 5,090.00 (1.39%) |
| Ex-Dividend Date | Jul 31, 2026 |
| Volume | 134,043 |
| Open | 370,500 |
| Previous Close | 367,000 |
| Day's Range | 358,000 - 371,000 |
| 52-Week Range | 204,000 - 475,000 |
| Beta | 1.02 |
| Analysts | Strong Buy |
| Price Target | 526,740.74 (+43.92%) |
| Earnings Date | Nov 5, 2026 |
About APR Co., Ltd.
APR Co., Ltd. manufactures and sells cosmetic products for men and women. The company also offers medical cosmetics and diet products. In addition, it provides electronic beauty products; and clothes through its online store. Additionally, the company operates an instant photo booth. It sells its products under the APRILSKIN, medicube, GLAM.D Bio, Forment, and NDY brand names. APR Co., Ltd. was founded in 2014 and is based in Seoul, South Korea. [Read more]
Financial Performance
In 2025, APR Co., Ltd.'s revenue was 1.53 trillion, an increase of 111.32% compared to the previous year's 722.75 billion. Earnings were 289.65 billion, an increase of 169.22%.
Financial StatementsAnalyst Summary
According to 27 analysts, the average rating for 278470 stock is "Strong Buy." The 12-month stock price target is ₩526,741, which is an increase of 43.92% from the latest price.
News
APR Co., Ltd. Earnings Call Transcript: Q2 2026
Q2 2026 saw record revenue and operating profit, driven by strong growth in North America and Europe, especially in the cosmetic and beauty segment. Full-year revenue guidance was raised to KRW 3 trillion, with air freight costs expected to ease as inventory stabilizes.
APR Co., Ltd. Slides: Q2 2026
APR Co., Ltd. has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
APR Co., Ltd. Quarterly report: Q2 2026
APR Co., Ltd. has published its Q2 2026 quarterly earnings report on August 5, 2026.
APR Co., Ltd. Earnings Call Transcript: Q1 2026
Record Q1 2026 revenue and profit driven by strong global demand, especially in the U.S. and Europe, with robust growth in cosmetics and beauty devices. Management expects continued healthy margins and stable growth, with new product launches and retail expansion planned.
APR Co., Ltd. Slides: Q1 2026
APR Co., Ltd. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
APR Co., Ltd. Quarterly report: Q1 2026
APR Co., Ltd. has published its Q1 2026 quarterly earnings report on May 6, 2026.
APR Co., Ltd. Earnings Call Transcript: Q4 2025
Q4 2025 saw revenue surge 124% YoY to KRW 548B and operating profit jump 228% to KRW 130B, with annual revenue doubling to KRW 1.5T. Overseas sales now comprise 80% of total, led by the U.S., and Medicube became Korea’s top beauty brand. 2026 guidance targets KRW 2.1T revenue and 25% margin.
APR Co., Ltd. Slides: Q4 2025
APR Co., Ltd. has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 3, 2026.
APR Co., Ltd. Annual report: Q4 2025
APR Co., Ltd. has published its Q4 2025 annual report on February 3, 2026.
APR Co., Ltd. Earnings Call Transcript: Q3 2025
Record Q3 2025 revenue and profit were driven by global expansion, strong U.S. and Japan growth, and successful promotions. Operating margin reached 25%, with overseas sales now 80% of total revenue. Outlook remains positive, with further offline and device segment expansion planned.
APR Co., Ltd. Slides: Q3 2025
APR Co., Ltd. has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 5, 2025.
APR Co., Ltd. Quarterly report: Q3 2025
APR Co., Ltd. has published its Q3 2025 quarterly earnings report on November 5, 2025.